
Molina Healthcare (MOH) announced preliminary Q2 adjusted earnings of approximately $5.50 per share, falling notably short of analyst consensus of $6.21, citing widespread medical cost pressures across all business lines. These pressures are expected to persist, prompting the company to sharply cut its fiscal 2025 adjusted earnings guidance to $21.50-$22.50 per share from a prior $24.50, significantly below Street expectations of $24.48.
Molina Healthcare (MOH) has pre-announced significantly weaker-than-expected preliminary financial results, signaling a deterioration in its core operating environment. The company's anticipated second-quarter adjusted earnings of approximately $5.50 per share fall substantially short of the $6.21 analyst consensus, a miss attributed to pervasive medical cost pressures across all three of its business segments. Critically, management expects these headwinds to persist into the second half of the year, undermining the company's forward-looking profitability. This is reflected in a severe downward revision of its fiscal 2025 adjusted earnings guidance to a range of $21.50 to $22.50 per share, a stark reduction from the previous forecast of $24.50 and well below the Street's estimate of $24.48. The guidance cut indicates that the elevated medical cost trend is not a transient issue and will materially impact earnings power in the medium term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.70
Ticker Sentiment